Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: The Bruneck study

Diabetes Care

Volumn 30, Issue 2, 2007, Pages 318-324

  Bonora, Enzo ^a,e   Kiechl, Stefan ^b   Willeit, Johann ^b   Oberhollenzer, Friedrich ^c   Egger, Georg ^c   Meigs, James B ^d   Bonadonna, Riccardo C ^a   Muggeo, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c BRUNECK HOSPITAL   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INCIDENCE; INSULIN RESISTANCE; ITALY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RISK FACTORS;

EID: 33846694838     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0919     Document Type: Article

References (54)

1. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 53:1782-1789, 2004
2. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
3. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
4. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47:1643-1649, 1998
5. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:703-706, 1989
6. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 365:1415-1428, 2005
7. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, Salonen JT, Karhapaa P: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
8. Bressler P, Bailey SR, Matsuda M, DeFronzo RA: Insulin resistance and coronary heart disease. Diabetologia 39:1345-1350, 1996
9. Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, Falezza G, Muggeo M: Intimal-medial thickness of the carotid artery in nondiabetic and non-insulin-dependent diabetic subjects: relationship with insulin resistance. Diabetes Care 20:627-631, 1997
10. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Emanuelli G: Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo. Diabetes 37:780-786, 1988
11. Kahn AM, Allen JC, Seidel CL, Zhang S: Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension 35:303-306, 2000
12. De Feo PP, Gaisano MG, Haymond MW: Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833-840, 1991
13. Jeschke MG, Klein D, Bolder U, Einspanier R: Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145:4084-4093, 2004
14. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A: Insulin infusion in acute illness. J Clin Invest 115:2069-2072, 2005
15. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, Lauro R: Insulin-dependent activation of eNOS is impaired by O-linked-glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106:466-472, 2002
16. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101:676-681, 2000
17. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R, Muggeo M: The metabolic syndrome: epidemiology and more extensive phenotypic description: cross-sectional data from the Bruneck Study. Int J Obes 27:1283-1289, 2003
18. Hak AE, Pols HA, Stehouwer CD, Mejer J, Kiliaan AJ, Hofman A, Bretler MM, Witteman JC: Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam Study. J Clin Endocrinol Metab 86:4398-4405, 2001
19. Carantoni M, Abbasi F, Warmerdam F, Klebanov M, Wang PW, Chen YD, Azhar S, Reaven GM: Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers. Arterioscler Thromb Vasc Biol 18:762-767, 1998
20. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni A: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
21. Yip J, Facchini F, Reaven GM: Resistance to insulin mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776, 1998
22. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 24:683-689, 2001
23. Hanley AJG, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25:1177-1184, 2002
24. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna RC, Muggeo M: HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: Prospective data from the Verona Diabetes Complications Study. Diabetes Care 25:1135-1141, 2002
25. Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L: Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 19:470-475, 2002
26. Robins SJ, Bloomfield Rubins H, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D, the VA-HIT Study Group: Insulin resistance and cardiovascular events with low HDL cholesterol: the Veteran Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 26:1513-1517, 2003
27. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV: Insulin resistance, the metabolic syndrome and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26:861-867, 2003
28. Matsumoto K, Sera Y, Abe Y, Ueki Y, Tominaga T, Miyake S: Inflammation and insulin resistance are independently related to all-cause and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis 169:317-321, 2003
29. Zethelius B, Lithell H, Hales CN, Berne C: Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease: a population-based 10-yr, follow-up study in 70-year-old men using the euglycemic glucose clamp. Diabetologia 48:862-867, 2005
30. Adler AI, Levy JC, Matthews DR, Stratton IM, Hines G, Holman RR: Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67). Diabet Med 22:306-311, 2005
31. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54:3252-3257, 2005
32. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefebvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Koranyi L, Laakso M, Mokan M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, the PROACTIVE Investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279-1289, 2005
33. Willeit J, Kiechl S: Prevalence and risk factors of asymptomatic extra-cranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb 13:661-668, 1993
34. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R, Muggeo M: Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck Study. Diabetes Care 26:1251-1257, 2003
35. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192, 2002
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
37. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degree of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
38. Report of the Fifth Working Group. IHD Register, Copenhagen, 1971
39. Walker A, Robins M, Weinfeld F: The National Survey of Stroke: clinical findings. Stroke 12 (Suppl. 1):13-49, 1981
40. O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes 33:596-603, 1984
41. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D: Reduction of inflammatory cytokine concentration and improvement of endothelial functions in obese women after weight loss for one year. Circulation 105:804-809, 2002
42. Nagi DK, Yudkin JS: Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects: a study of two ethnic groups. Diabetes Care 16:621-629, 1993
43. Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA: Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med 134:61-71, 2001
44. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
45. Langenfeld MR, Forst T, Hohberg C, Kann P, Lubben G, Konrad T, Fullert SD, Sachara C, Pfutzner A: Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation 111:2525-2531, 2005
46. Choi D, Kim SK, Choi SE, Ko YG, Ahn CW, Jang Y, Lim SK, Lee HC, Cha BS: Preventive effect of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. Diabetes Care 27:2654-2660, 2004
47. Nagi DK, Tracy R, Pratley R: Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians. Metabolism 45:1243-1247, 1996
48. Bonadonna R, Bonora E: Glucose and free fatty acid metabolism in human obesity: relationship with insulin resistance. Diabetes Rev 5:21-51, 1997
49. Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. Diabetologia 45:623-634, 2002
50. Jouven X, Charles MA, Desnos M, Ducimetière P: Circulating nonesterified fatty acid level as predictive risk factor for sudden death in the population. Circulation 104:756-761, 2001
51. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994
52. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davey Smith G: Concentrations of proinsulin-like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly study. Diabetologia 45:327-336, 2002
53. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, Nair KS: Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52:1888-1896, 2003
54. Oguma Y, Shinoda-Tagawa T: Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. Am J Prev Med 26:407-418, 2004